Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript March 15, 2024 Autolus Therapeutics plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics’ Call to discuss the Full Year 2023 […]
Here is how Ascendis Pharma A/S (ASND) and Autolus Therapeutics PLC Sponsored ADR (AUTL) have performed compared to their sector so far this year.
Autolus Therapeutics PLC Sponsored ADR (AUTL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.